Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Assets Average: 2020-2025

Historic Assets Average for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to $1.8 billion.

  • Avidity Biosciences' Assets Average rose 17.23% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 17.23%. This contributed to the annual value of $1.1 billion for FY2024, which is 72.99% up from last year.
  • According to the latest figures from Q3 2025, Avidity Biosciences' Assets Average is $1.8 billion, which was up 23.87% from $1.4 billion recorded in Q2 2025.
  • Avidity Biosciences' 5-year Assets Average high stood at $1.8 billion for Q3 2025, and its period low was $302.6 million during Q2 2021.
  • Moreover, its 3-year median value for Assets Average was $1.1 billion (2024), whereas its average is $1.1 billion.
  • Data for Avidity Biosciences' Assets Average shows a peak YoY skyrocketed of 166.67% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Avidity Biosciences' Assets Average stood at $426.7 million in 2021, then grew by 25.29% to $534.7 million in 2022, then increased by 12.38% to $600.9 million in 2023, then skyrocketed by 166.67% to $1.6 billion in 2024, then climbed by 17.23% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.5 billion during Q1 2025.